Risk Factors for Gout in Taiwan Biobank: A Machine Learning Approach

台湾生物库中痛风风险因素的机器学习方法

阅读:1

Abstract

PURPOSE: We assessed the risk of gout in the Taiwan Biobank population by applying various machine learning algorithms. The study aimed to identify crucial risk factors and evaluate the performance of different models in gout prediction. PATIENTS AND METHODS: This study analyzed data from 88,210 individuals in the Taiwan Biobank, identifying 19,338 cases of gout and 68,872 controls. After data cleaning and propensity score matching for gender and age, the final analytical sample comprised 38,676 individuals (19,338 gout cases and 19,338 controls). Five machine learning models were used: Bayesian Network (BN), Random Forest (RF), Gradient Boosting (GB), Logistic Regression (LR), and Neural Network (NN). The predictive performance was evaluated using a split dataset (80% training set and 20% test set). RESULTS: Variable importance analysis was performed to identify key variables, with uric acid and gender emerging as the most influential risk factors. Descriptive data highlighted significant differences between the control group and gout patients, with a higher prevalence of gout in men (51.36% vs 48.64%). Both the RF and GB demonstrated high performance across multiple metrics, with RF consistently achieving a high area under the curve (AUC) of 0.986 to 0.987, alongside excellent sensitivity (0.945-0.947) and specificity (0.998-0.999). GB also performed robustly, with AUC values around 0.987-0.988 and maintaining high sensitivity (0.944-0.950) and specificity (0.995-0.999) across different model variations. The F1 scores for both models (GB and RF) indicate strong predictive capabilities, with values around 0.971-0.972. CONCLUSION: The RF and GB demonstrated exceptional accuracy in predicting gout status, particularly when incorporating genetic data alongside clinical factors. These findings underscore the potential for integrating machine learning models with genetic information to enhance gout prediction accuracy in clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。